CA12 and neoplasm: Animal experiments have demonstrated that the expression level of CA XII is positively correlated with tumor size and metastasis, and treatment with CA XII inhibitors resulted in reduced tumor volume and lower invasiveness in mouse models, confirming its potential as a therapeutic target [59,60,61].